Role of Cdk Phosphorylation of HsCdc6 in DNA Replication

HsCdc6 Cdk 磷酸化在 DNA 复制中的作用

基本信息

项目摘要

In all eukaryotic cells, accurate duplication of chromosomes and precise segregation of the sister chromatids into two daughter chromosomes are essential for faithful propagation of their identity. The first event, DNA replication, is a tightly regulated process that is strictly coupled to the progression of the cell cycle. It occurs at discrete chromosomal locations (replication origins) during the S-phase of the cell cycle. When DNA replication is initiated, the cell must ensure that all of its genome is replicated and that the replication of every DNA section occurs once and only once per cell cycle. HsCdc6, a human protein homolog to the budding yeast DNA replication protein Cdc6p, plays an essential role in the initiation of DNA replication in human cells. Like all Cdc6-related proteins, HsCdc6 contains a bipartite Walker nucleotide-binding motif and shows significant sequence similarity to the eukaryotic and prokaryotic clamp loaders that load ring-shaped DNA polymerase processivity factors onto DNA. Recent studies have shown that HsCdc6 has intrinsic ATP binding and ATPase activity, which play important roles in regulating the initiation of DNA replication. HsCdc6 is a physiological substrate of cyclin-dependent kinase (Cdk). Cdk phosphorylation of HsCdc6 is required for the initiation of DNA replication and results in its nuclear exclusion via a receptor-dependent nuclear export. Therefore, it is suggested that Cdk phosphorylation of HsCdc6 prevents its reassociation with chromatin, thereby preventing DNA re-replication. Nevertheless, the exact mechanisms by which phosphorylation of HsCdc6 by Cdk is needed for the initiation and how phosphorylated HsCdc6 is specifically exported from the nucleus are unclear. Determination of these mechanisms is the goal of this project. The first aim of the project is to determine how Cdk phosphorylation of HsCdc6 regulates the initiation of DNA replication. Recombinant HsCdc6 and its Cdk phosphorylation mutants will be purified from insect cells using the baculovirus-based express system. Purified HsCdc6 proteins will be used to determine whether Cdk phosphorylation of HsCdc6 regulates its intrinsic ATP binding and/or ATPase activity. Moreover, the functional roles of Cdk phosphorylation of HsCdc6 in regulating the initiation of DNA replication will be determined using the Xenopus cell-free DNA replication system. The second aim of this project is to determine the nucleocytoplasmic transport pathway that regulates the nuclear export of Cdk phosphorylated HsCdc6 and identify factor(s) that specifically regulates the process by in vitro binding protein purification or yeast two-hybrid screen strategies. This will ultimately lead to elucidation of the molecular mechanism by which Cdk phosphorylation of HsCdc6 prevents DNA re-replication in mammalian cells. These studies will contribute to a better understanding of the function roles of Cdk phosphorylation of HsCdc6 in regulating the initiation of DNA replication and preventing DNA re-replication. The results will also lead to a better understanding of the fundamental biological processes of DNA replication and nucleocytoplasmic transport, which are still enigmatic in higher eukaryotes.
在所有真核细胞中,染色体的精确复制和姐妹染色单体精确地分离到两条子代染色体中,对于其身份的忠实传播是必不可少的。第一个事件,DNA复制,是一个严格受控的过程,严格地与细胞周期的进展相联系。在细胞周期的S阶段,它发生在离散的染色体位置(复制起点)。当DNA复制开始时,细胞必须确保其所有基因组都被复制,并且每个DNA片段的复制在每个细胞周期中只发生一次。HsCDC6是一种与发芽酵母DNA复制蛋白CDC6p同源的人类蛋白,在人类细胞DNA复制的启动中起着至关重要的作用。与所有与CDC6相关的蛋白质一样,HsCDC6含有一个二段Walker核苷酸结合基序,并与真核和原核生物将环状DNA聚合酶活性因子装载到DNA上的钳夹加载器显示出显著的序列相似性。最近的研究表明,HsCDC6具有内在的ATP结合和ATPase活性,它们在调节DNA复制的启动中发挥着重要作用。HsCDC6是细胞周期蛋白依赖性激酶(CDK)的生理底物。HsCDC6的CDK磷酸化是启动DNA复制所必需的,并通过受体依赖的核输出导致其核排斥。因此,我们认为CDK对HsCDC6的磷酸化阻止了它与染色质的重新结合,从而阻止了DNA的再次复制。然而,CDK对HsCDC6的磷酸化所需的确切机制以及磷酸化的HsCDC6是如何从细胞核中特异性输出的尚不清楚。确定这些机制是本项目的目标。该项目的第一个目标是确定HsCDC6的CDK磷酸化如何调节DNA复制的启动。利用基于杆状病毒的表达系统从昆虫细胞中纯化重组HsCDC6及其CDK磷酸化突变体。纯化的HsCDC6蛋白将被用来确定HsCDC6的CDK磷酸化是否调节其固有的ATP结合和/或ATPase活性。此外,利用非洲爪哇无细胞DNA复制系统,将确定HsCDC6的CDK磷酸化在调节DNA复制启动中的功能作用。本项目的第二个目标是确定调控CDK磷酸化HsCDC6核输出的核质转运途径,并通过体外结合蛋白纯化或酵母双杂交筛选策略识别特异性调控这一过程的因子(S)。这将最终导致阐明CDK磷酸化HsCDC6阻止DNA在哺乳动物细胞中重新复制的分子机制。这些研究将有助于更好地理解HsCDC6的CDK磷酸化在调节DNA复制起始和防止DNA再次复制中的功能作用。这些结果还将有助于更好地理解DNA复制和核质运输的基本生物学过程,这些过程在高等真核生物中仍然是谜。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wei Jiang其他文献

Experimental Demonstration of Mixed-Polarization to Linearize Electro-Absorption Modulators in Radio-Over-Fiber Links
光纤无线电链路中电吸收调制器混合偏振线性化的实验演示
  • DOI:
    10.1109/lpt.2010.2098474
  • 发表时间:
    2011-02
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Bouchaib Hraimel;Xiupu Zhang;Wei Jiang;Ke Wu;Taijun Liu;Tiefeng Xu;Qiuhua Nie;Kun Xu
  • 通讯作者:
    Kun Xu
Deferred cash compensation and risk-taking: Evidence from the Chinese banking industry
递延现金补偿与风险承担:来自中国银行业的证据
  • DOI:
    10.1016/j.pacfin.2018.12.005
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Wei Jiang;Yunguo Liu;Gerald J.Lobo;Yue Xu
  • 通讯作者:
    Yue Xu
Theoretical simulation study on crystal property and hygroscopicity of ADN doping with nitramine explosives (RDX, HMX, and CL-20)
硝胺炸药(RDX、HMX、CL-20)掺杂ADN晶体性质及吸湿性的理论模拟研究
  • DOI:
    10.1007/s00894-022-05200-0
  • 发表时间:
    2022-07
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Qiangqiang Lu;Lei Xiao;Yinglei Wang;Guangpu Zhang;Yubing Hu;Fuyao Chen;Fengqi Zhao;Junqing Yang;Wei Jiang;Gazi Hao
  • 通讯作者:
    Gazi Hao
Ultra-Broadband, Fabrication Tolerant Optical Coupler for Arbitrary Splitting Ratio Using Particle Swarm Optimization Algorithm
使用粒子群优化算法实现任意分光比的超宽带、可制造容差光耦合器
  • DOI:
    10.1109/jphot.2020.3029059
  • 发表时间:
    2020-10
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Lemeng Leng;Minfeng Jin;Zhongzhi Lin;Chenbin Zhang;Ding Ding;Wei Jiang
  • 通讯作者:
    Wei Jiang
Investigation of the near-threshold cluster resonance in C-14
C-14 中近阈值团簇共振的研究
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Hong-Liang Zang;Yan-Lin Ye;Zhi-Huan Li;Jian-Song Wang;Jian-Ling Lou;Qi-Te Li;Yu-Cheng Ge;Xiao-Fei Yang;Jing Li;Wei Jiang;Jun Feng;Qiang Liu;Biao Yang;Zhi-Qiang Chen;Yang Liu;Hong-Yi Wu;Chen-Yang Niu;Chen-Guang Li;Chun-Guang Wang;Xiang Wang;Wei Liu;Jian Ga
  • 通讯作者:
    Jian Ga

Wei Jiang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wei Jiang', 18)}}的其他基金

TWC SBE: Medium: Collaborative: Building a Privacy-Preserving Social Networking Platform from a Technological and Sociological Perspective
TWC SBE:媒介:协作:从技术和社会学角度构建保护隐私的社交网络平台
  • 批准号:
    1855391
  • 财政年份:
    2018
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
TWC SBE: Medium: Collaborative: Building a Privacy-Preserving Social Networking Platform from a Technological and Sociological Perspective
TWC SBE:媒介:协作:从技术和社会学角度构建保护隐私的社交网络平台
  • 批准号:
    1564101
  • 财政年份:
    2016
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
I-Corps: An Outsourced and Completely Private Social Network: You&Me
I-Corps:一个外包且完全私有的社交网络:您
  • 批准号:
    1522781
  • 财政年份:
    2015
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
TC:Large:Collaborative Research:Anonymizing Textual Data and its Impact on Utility
TC:大型:协作研究:匿名文本数据及其对实用性的影响
  • 批准号:
    1011984
  • 财政年份:
    2010
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
Collaborative Research: Predatory Lending, Predatory Borrowing, and the Mortgage Crisis: Evidence from Loan-Level Data from a Large Bank
合作研究:掠夺性贷款、掠夺性借款和抵押危机:来自大型银行贷款水平数据的证据
  • 批准号:
    0851428
  • 财政年份:
    2009
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Continuing Grant
STTR Phase I: Fully Embedded Optical Interconnect Layers Based on Molded Polymer Lightwave Components for Large Field Size Printed Circuit Boards
STTR 第一阶段:用于大面积印刷电路板的基于模制聚合物光波组件的完全嵌入式光学互连层
  • 批准号:
    0539538
  • 财政年份:
    2006
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
CAREER: Data Quality Management through Statistical Quality Control and Data Mining
职业:通过统计质量控制和数据挖掘进行数据质量管理
  • 批准号:
    0542881
  • 财政年份:
    2006
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Continuing Grant
Role of Cdk Phosphorylation of HsCdc6 in DNA Replication
HsCdc6 Cdk 磷酸化在 DNA 复制中的作用
  • 批准号:
    0078432
  • 财政年份:
    2000
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Continuing Grant

相似国自然基金

B3GAT3介导CDK4蛋白糖基化修饰促进肝癌细胞衰老抵抗与HCC发生发展的机制与转化研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
BK多瘤病毒通过大T抗原调控CDK1建立移 植肾小管上皮细胞内病毒复制微环境的 机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
USP11介导的CDK10去泛素化调控JNK/c-JUN信号通路抑制肺癌肿瘤形成与放疗抵抗的作用与机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
EBV-miR-BART19-3p抑制GADD45B增强cyclinB1/CDK1结合促进EBV相关胃癌细胞增殖的机制研究
  • 批准号:
    2025JJ81046
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
环状RNA circCHD7通过稳定CDK11B蛋白从而促进骨肉瘤发生发展的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Kyn通过CDK4-MDM2-P53通路调控沙眼衣原体持续感染的作用机制
  • 批准号:
    2025JJ50556
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
酸性微环境通过诱导肿瘤相关巨噬细胞M2极化促进ER+乳腺癌CDK4/6抑制剂耐药的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
一种包载四价铂药和CDK1抑制剂的纳米粒用于靶向治疗复发/转移性鼻咽癌的效果及其机制研究
  • 批准号:
    2025JJ70550
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
青蒿琥酯调控Nrf2/HO-1-Cycin D1/CDK4-pRB信号轴诱导甲状腺相关眼病成纤维细胞衰老的机制研究
  • 批准号:
    2025JJ60577
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

転写調節型CDK阻害剤が著効を示すがんの層別化を可能とする抗がん分子機序の解明
阐明转录调节 CDK 抑制剂有效的癌症分层的抗癌分子机制
  • 批准号:
    23K06622
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs
对老年乳腺癌患者实施老年评估以优化 CDK 4/6 抑制剂的剂量
  • 批准号:
    10072029
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    EU-Funded
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
  • 批准号:
    10554474
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Cyclin-dependent kinase (CDK)19-mediated vein graft intimal hyperplasia
细胞周期蛋白依赖性激酶(CDK)19介导的静脉移植内膜增生
  • 批准号:
    10664327
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Improving CDK 4/6 inhibition in the treatment of medulloblastoma
改善髓母细胞瘤治疗中的 CDK 4/6 抑制
  • 批准号:
    10321539
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
Elucidation of the meiotic regulatory network by CDK and TOR
CDK 和 TOR 阐明减数分裂调控网络
  • 批准号:
    21K14785
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Metabolomics with alternative decision tree-based machine learning methods for the prediction of cdk 4/6 inhibitor efficacy
使用基于替代决策树的机器学习方法的代谢组学用于预测 cdk 4/6 抑制剂功效
  • 批准号:
    21K08676
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
転写調節CDK阻害薬による大腸癌の癌幹細胞性の抑制
转录 CDK 抑制剂抑制结直肠癌的癌症干细胞
  • 批准号:
    21K07216
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of Ferroptosis by the p53/CDK/Rb Axis.
p53/CDK/Rb 轴对铁死亡的调节。
  • 批准号:
    10203213
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
Regulation of Ferroptosis by the p53/CDK/Rb Axis.
p53/CDK/Rb 轴对铁死亡的调节。
  • 批准号:
    10632830
  • 财政年份:
    2021
  • 资助金额:
    $ 16.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了